Carl KestensMar 11, 20224 minTHE TEN BILLION UNICORN IN INMUNE BIO: THE TESTIMONIALS SO FARIntroduction Apart from the abundant preclinical data showing efficacy in animals, XPro has been tested in six patients in the Phase 1...
Carl KestensMar 8, 20226 minNFL AS A HIGHLY RELEVANT BIOMARKER IN AD AND OTHER NEUROLOGICAL DISEASESWhat is neurofilament-light chain (NfL)? Neurofilaments, the larger group to which NfL belongs, are structural components of neuronal...
Carl KestensMar 7, 20229 minANNOVIS: BUNTANETAP/ANVS-401/POSIPHEN AND MY THOUGHTS ON THE PREVIOUSLY REJECTED PHENSERINEA small recap of existing drugs approved for AD There are four FDA-approved drugs for Alzheimer’s disease, three of which are...
Carl KestensMar 6, 20226 minTHE CURIOUS CASE OF CORTEXYME AND HOW I RELATE IT TO INMUNE BIO What most investors seem to forget is diving into scientific literature The trials and tribulations of the stock market seem, to me, in...